NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Fish Oil and Gemfibrozil: what the published research says

PubMed indexes 4 records that name Fish Oil and Gemfibrozil together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Fish Oil and Gemfibrozil. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

4 studies naming Fish Oil and Gemfibrozil.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.

Journal of acquired immune deficiency syndromes (1999) · 2013 · PMID 23892238

Multicenter StudyObservational StudyResearch Support, N.I.H., ExtramuralHuman subjects493 participants

“In HIV-infected patients in routine clinical care, fish oil is less effective than fibrates (but not atorvastatin) at lowering TG values. Fish oil may still represent an attractive alternative for patients with moderately elevated TGs, particularly among patients who may not want or tolerate fibrates.”

Muñoz et al. · Authors' conclusion

Names both Fish Oil and Gemfibrozil in its title.

Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1996 · PMID 8738112

Clinical TrialComparative StudyRandomized Controlled Trial

“We concluded, based on short-time applications, that (a) neither treatment affected the carbohydrate metabolism in patients with NIDDM, and (b) a greater hypolipidemic efficacy had to be assigned to Gemfibrozil than to fish oil. It would therefore appear that Gemfibrozil acts as a useful lipostatic pharmacologic compound, whilst fish oil could serve as a potential ingredient of a prudent cardio-protective diet which favours the low plasma triglyceride concentrations found in…”

Fasching et al. · From the abstract

Names both Fish Oil and Gemfibrozil in its title.

Combined therapy in the treatment of dyslipidemia.

Fundamental & clinical pharmacology · 2010 · PMID 19682080

Systematic ReviewHuman subjects

Names Fish Oil and Gemfibrozil together in an interaction, co-administration, or pharmacokinetic context.

Comparison table: Some lipid-lowering drugs.

The Medical letter on drugs and therapeutics · 2019 · PMID 30845107

Comparative StudyHuman subjects

Names Fish Oil and Gemfibrozil together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Fish Oil, Gemfibrozil, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.